The global ketamine clinic market size is calculated at USD 1.52 billion in 2025 and is forecasted to reach around USD 3.35 billion by 2034, accelerating at a CAGR of 9.20% from 2025 to 2034. The North America market size surpassed USD 653.3 million in 2024 and is expanding at a CAGR of 9.31% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Ketamine Clinic Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Ketamine Clinic Market, by Treatment Type
8.1.1 Depression
8.1.1.1. Market Revenue and Forecast
8.1.2. Anxiety disorders
8.1.2.1. Market Revenue and Forecast
8.1.3. Post-traumatic stress disorder
8.1.3.1. Market Revenue and Forecast
8.1.4. Chronic pain
8.1.4.1. Market Revenue and Forecast
8.1.5. Substance use disorders
8.1.5.1. Market Revenue and Forecast
9.1. Ketamine Clinic Market, by Route of Administration
9.1.1. Intravenous
9.1.1.1. Market Revenue and Forecast
9.1.2. Intramuscular
9.1.2.1. Market Revenue and Forecast
9.1.3. Nasal
9.1.3.1. Market Revenue and Forecast
9.1.4. Oral
9.1.4.1. Market Revenue and Forecast
9.1.5. Sublingual
9.1.5.1. Market Revenue and Forecast
10.1. Ketamine Clinic Market, by Patient Demographics
10.1.1. Adults
10.1.1.1. Market Revenue and Forecast
10.1.2. Children
10.1.2.1. Market Revenue and Forecast
10.1.3. Geriatric
10.1.3.1. Market Revenue and Forecast
10.1.4. Veterans
10.1.4.1. Market Revenue and Forecast
10.1.5. Pregnant women
10.1.5.1. Market Revenue and Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Treatment Type
11.1.2. Market Revenue and Forecast, by Route of Administration
11.1.3. Market Revenue and Forecast, by Patient Demographics
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Treatment Type
11.1.4.2. Market Revenue and Forecast, by Route of Administration
11.1.4.3. Market Revenue and Forecast, by Patient Demographics
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Treatment Type
11.1.5.2. Market Revenue and Forecast, by Route of Administration
11.1.5.3. Market Revenue and Forecast, by Patient Demographics
11.2. Europe
11.2.1. Market Revenue and Forecast, by Treatment Type
11.2.2. Market Revenue and Forecast, by Route of Administration
11.2.3. Market Revenue and Forecast, by Patient Demographics
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Treatment Type
11.2.4.2. Market Revenue and Forecast, by Route of Administration
11.2.4.3. Market Revenue and Forecast, by Patient Demographics
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Treatment Type
11.2.5.2. Market Revenue and Forecast, by Route of Administration
11.2.5.3. Market Revenue and Forecast, by Patient Demographics
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Treatment Type
11.2.6.2. Market Revenue and Forecast, by Route of Administration
11.2.6.3. Market Revenue and Forecast, by Patient Demographics
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Treatment Type
11.2.7.2. Market Revenue and Forecast, by Route of Administration
11.2.7.3. Market Revenue and Forecast, by Patient Demographics
11.3. APAC
11.3.1. Market Revenue and Forecast, by Treatment Type
11.3.2. Market Revenue and Forecast, by Route of Administration
11.3.3. Market Revenue and Forecast, by Patient Demographics
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Treatment Type
11.3.4.2. Market Revenue and Forecast, by Route of Administration
11.3.4.3. Market Revenue and Forecast, by Patient Demographics
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Treatment Type
11.3.5.2. Market Revenue and Forecast, by Route of Administration
11.3.5.3. Market Revenue and Forecast, by Patient Demographics
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Treatment Type
11.3.6.2. Market Revenue and Forecast, by Route of Administration
11.3.6.3. Market Revenue and Forecast, by Patient Demographics
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Treatment Type
11.3.7.2. Market Revenue and Forecast, by Route of Administration
11.3.7.3. Market Revenue and Forecast, by Patient Demographics
11.4. MEA
11.4.1. Market Revenue and Forecast, by Treatment Type
11.4.2. Market Revenue and Forecast, by Route of Administration
11.4.3. Market Revenue and Forecast, by Patient Demographics
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Treatment Type
11.4.4.2. Market Revenue and Forecast, by Route of Administration
11.4.4.3. Market Revenue and Forecast, by Patient Demographics
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Treatment Type
11.4.5.2. Market Revenue and Forecast, by Route of Administration
11.4.5.3. Market Revenue and Forecast, by Patient Demographics
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Treatment Type
11.4.6.2. Market Revenue and Forecast, by Route of Administration
11.4.6.3. Market Revenue and Forecast, by Patient Demographics
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Treatment Type
11.4.7.2. Market Revenue and Forecast, by Route of Administration
11.4.7.3. Market Revenue and Forecast, by Patient Demographics
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Treatment Type
11.5.2. Market Revenue and Forecast, by Route of Administration
11.5.3. Market Revenue and Forecast, by Patient Demographics
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Treatment Type
11.5.4.2. Market Revenue and Forecast, by Route of Administration
11.5.4.3. Market Revenue and Forecast, by Patient Demographics
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Treatment Type
11.5.5.2. Market Revenue and Forecast, by Route of Administration
11.5.5.3. Market Revenue and Forecast, by Patient Demographics
12.1. The Answers Clinic
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Delic Holdings
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Ketamine Wellness Centers
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. The Ketamine Clinic
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Clarity Clinic
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Neuro Wellness Spa
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. New Mind Health
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Revitalist Lifestyle and Wellness
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Somi Vitamin
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Psychedelic Science
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample